Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

Exclusion Criteria

• •1. History of type 1 diabetes, diabetic ketoacidosis, "brittle" diabetes or frequent hypoglycemia or severe hypoglycemic episodes requiring emergent intervention (ER visit or EMS response, glucagon administration or forced oral carbs) in the last 6 months
• •2. Use of an SGLT2 inhibitor within the prior 30 days
• •3. 1 or more episodes of peritonitis in the previous 6 months or active infection of the peritoneal dialysis catheter
• •4. Anemia with hemoglobin \<8g/dL
• •5. Inability to give written informed consent or follow study protocol
• •6. Contraindication to receiving loop diuretics